Lin Ruichao, director of the Research and Testing Center of Traditional Chinese Medicine Standards for Chinese Food and Drug Inspection and Research Institute, told reporters from China Securities Journal，"Chinese Pharmacopoeia" (2015 edition) has begun revision。The new version of the national basic drug directory is also in the formulation and adjustment stage，It is expected that the recent early warning of traditional Chinese medicine injection will not affect the status of Chinese medicine injection in the new version of the basic medicine directory.。
But Lin Ruichao said at the same time，2015 version of the Chinese Pharmacopoeia preparation outline requires further strengthening the safety control of high -risk Chinese medicine injection，Study and establish an abnormal toxicity of traditional Chinese medicine injection、Allergic reaction、Polymer stake online sports bettingpolymer、protein、New methods related to material examination。Explore the feasibility of the sterilization method of Zhongcheng Pharmaceutical Specification into the standard text of the Pharmacopoeia to ensure security and promote industrial progress。
Chinese medicine safety continues to tighten
According to an introduction，The new version of Chinese Pharmacopoeia will improve the standard，Improve the level of safety control of traditional Chinese medicine。Study on a systematic safety of Chinese medicinal materials and slices，Implementation in stages，Create a national database，Proposal and formulate the dosage and reasonable range of safe medication; formulate endogenous toxic ingredients and exogenous heavy metals and harmful residues (pesticide residues、Carbon dioxide、fungal toxin、Cobalt-60 Discipline、Solvent residue, etc.) Control method、limit。Use poisoning small、Little pollution、Save resources、Protecting the environment、Simple and practical detection method。Fully stop the toxic reagents such as benzene and replace it all。
In addition, the quality control of the effectiveness of Chinese medicinal materials will be strengthened。For the dependence of the existence of obvious place of origin and the strict requirements for growth periods,，To increase the relevant regulations of the place of origin and harvesting life，Strengthening the quality standard comparative research and quality control method of the quality standards of wild and cultivation，Ensure quality from the source。
The new version of Chinese Pharmacopoeia will strive for 100 Chinese medicine standards to stake online sports bettingreach international bilateral or multilateral mutual recognition，Establish the dominant position of "Chinese Pharmacopoeia" in international pharmacopoeia coordination and standard formulation，Establish and improve the formation and elimination mechanism of national drug standards，Promote industrial optimization and upgrade。In addition, it will study and improve the alternative method of standard substances of traditional Chinese medicine。Establish and improve the technical method of controlling endogenous toxic ingredients and exogenous harmful substances，Gradually establish toxic Chinese medicine and commonly used Chinese medicinal materials、Safety database of drinks。Actively explore and vigorously implement the quality evaluation system based on Chinese medicine control extract。
Lin Ruichao said，It will further improve the structure of the Chinese Pharmacopoeia，Make the variety of drugs to meet the national basic drug directory、National Basic Medical Insurance, etc.，Make drug safety guarantee and quality control level further improve，Traditional Chinese Medicine Standard Leading International Development，Chemical drugs and biological products standards have reached or close to international levels，Make the national drug standard system more complete and perfect。
Pharmaceutical auxiliary materials receive key attention
Medicinal Accessories will be separated in the 2015 version of the Chinese Pharmacopoeia，Quantity will be significantly higher than the 2010 version of the Pharmacopoeia，This has attracted the attention of the supervision of pharmaceutical auxiliary materials in the post -"poison capsule" era in the industry。
A reporter from China Securities News learned，Poison Capsule stake betting appincident reflects the hidden safety hazards of the medicinal auxiliary materials industry cannot be underestimated。2015 Pharmacopoeia will increase the standard of medicinal accessories，Improve industry supervision。According to an introduction，2015 version of the Pharmacopoeia will increase the number of medicinal accessories to about 400 kinds，In the 2010 version of the pharmacopoeia, this number is only 130 kinds。In addition，The State Food and Drug Administration will explore the implementation of the implementation of medication accessories filing management system，Promote the improvement of drug production safety。
The State Drug Administration has publicly solicited opinions on the "Related Regulations on Strengthening the Supervision and Management of Medical Accessories" last month，and will be officially implemented from October 1。The "Regulations" indicates，Pharmaceuticals will be managed by reference to the raw medicine，Increase regulatory strength，and improve and improve the standards of medicinal auxiliary materials as the current work focus。
Dested，Since entering the "Twelfth Five -Year Plan"，Small in the medicinal auxiliary materials industry、San、The chaotic production pattern has aroused the attention of the industry。
The "Twelfth Five -Year Plan" of the Ministry of Industry and Information Technology and the "Twelfth Five -Year Plan for National Drug Safety" issued by the State Council and the State Council all incorporate the pharmaceutical auxiliary materials industry into the key development and regulatory field，and said that at the end of the "Twelfth Five -Year Plan", 100%of the new version of GMP development stake sports betting apptarget，This will bring new development opportunities to the accessories industry。The preparation outline of the new version of the Chinese Pharmacopoeia also reflects the importance of drug safety，The first principle is to ensure the safety of public medication，The overall target includes drug safety guarantee and the level of quality control to be further improved。
